🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Food allergy is a serious public health concern that causes potentially-lif...
Status
Completed
Location
University of California Los Angeles (UCLA)
Start Date
2020-02-05
Trial ID
NCT03679676
Treatments Being Tested
This research is being done to study the effects of the drug omalizumab (Xo...
Status
Completed
Location
Johns Hopkins Asthma and Allergy Center
Start Date
2007-07
Trial ID
NCT00604786
Treatments Being Tested
The study is a Phase II, dose-ranging, multicenter, randomized, double-blin...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00866788
Treatments Being Tested
This study will assess the efficacy, safety and tolerability of omalizumab,...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-09
Trial ID
NCT01202903
Treatments Being Tested
A substance called immunoglobulin E (IgE), which is naturally produced by o...
Status
Completed
Location
Alabama Allergy and Asthma Center
Start Date
2004-04
Trial ID
NCT00079937
Treatments Being Tested
The study is a global Phase III, multicenter, randomized, double-blind, pla...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01264939
In this project, the investigators would like to learn if 24 weeks (about 5...
Status
Recruiting
Location
Johns Hopkins
Start Date
2025-05-19
Trial ID
NCT06934200
Treatments Being Tested
The purpose of the core phase of the trial is to assess the efficacy, safet...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2023-11-15
Trial ID
NCT06042478
Treatments Being Tested
The purpose of this study was to demonstrate the efficacy and safety of oma...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-12-15
Trial ID
NCT03369704
Treatments Being Tested
This study will evaluate the efficacy of QGE031 compared to omalizumab in p...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-11
Trial ID
NCT01703312
Treatments Being Tested